PMID- 16785544 OWN - NLM STAT- MEDLINE DCOM- 20060809 LR - 20190516 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 177 IP - 1 DP - 2006 Jul 1 TI - Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival. PG - 468-78 AB - We investigated the role of reactive oxygen species (ROS) in dendritic cell (DC) differentiation by 10-kDa Mycobacterium tuberculosis secretory Ag (MTSA) and survival of mycobacteria therein. Compared with GM-CSF, MTSA induced lower ROS production during DC differentiation from precursors. This result correlated with higher superoxide dismutase 1 expression in MTSA stimulated precursors as compared with GM-CSF stimulation. Furthermore, a negative regulation of protein kinase C (PKC) activation by ROS was observed during DC differentiation. ROS inhibited the rapid and increased phosphorylation of PKCalpha observed during DC differentiation by MTSA. In contrast, ROS inhibition increased the weak and delayed PKCalpha phosphorylation by GM-CSF. Similar to DC differentiation, upon activation with either M. tuberculosis cell extract (CE) or live Mycobacterium bovis bacillus Calmette-Guerin (BCG), DCs differentiated with MTSA (MTSA-DCs) generated lower ROS levels when compared with DCs differentiated with GM-CSF (GM-CSF-DCs). Likewise, a negative regulation of PKCalpha phosphorylation by ROS was once again observed in DCs activated with either M. tuberculosis CE or live M. bovis BCG. However, a reciprocal positive regulation between ROS and calcium was observed. Compared with MTSA-DCs, stimulation of GM-CSF-DCs with M. tuberculosis CE induced a 2-fold higher ROS-dependent calcium influx. However, pretreatment of MTSA-DCs with H(2)O(2) increased calcium mobilization. Finally, lower ROS levels in MTSA-DCs correlated with increased intracellular survival of M. bovis BCG when compared with survival in GM-CSF-DCs. Although inhibiting ROS in GM-CSF-DCs increased M. bovis BCG survival, H(2)O(2) treatment of MTSA-DCs decreased survival of M. bovis BCG. Overall our results suggest that DCs differentiated with Ags such as MTSA may provide a niche for survival and/or growth of mycobacteria following sequestration of ROS. FAU - Sinha, Aprajita AU - Sinha A AD - Immunology Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India. FAU - Singh, Anjana AU - Singh A FAU - Satchidanandam, Vijaya AU - Satchidanandam V FAU - Natarajan, Krishnamurthy AU - Natarajan K LA - eng GR - AI 75320/AI/NIAID NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Bacterial Proteins) RN - 0 (CFP-10 protein, Mycobacterium tuberculosis) RN - 0 (Reactive Oxygen Species) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) RN - EC 1.15.1.1 (Sod1 protein, mouse) RN - EC 1.15.1.1 (Superoxide Dismutase) RN - EC 1.15.1.1 (Superoxide Dismutase-1) RN - EC 2.7.11.13 (Protein Kinase C) SB - IM MH - Animals MH - Bacterial Proteins/*physiology MH - Calcium Signaling/immunology MH - Cell Differentiation/*immunology MH - Cells, Cultured MH - Dendritic Cells/enzymology/immunology/*metabolism/*microbiology MH - Down-Regulation/immunology MH - Female MH - Granulocyte-Macrophage Colony-Stimulating Factor/physiology MH - Intracellular Fluid/enzymology/immunology/*microbiology MH - Mice MH - Mice, Inbred BALB C MH - Mycobacterium bovis/immunology MH - Mycobacterium tuberculosis/*growth & development/immunology/pathogenicity MH - Protein Kinase C/antagonists & inhibitors/metabolism MH - Reactive Oxygen Species/*antagonists & inhibitors/immunology/metabolism MH - Superoxide Dismutase/physiology MH - Superoxide Dismutase-1 MH - Up-Regulation/immunology EDAT- 2006/06/21 09:00 MHDA- 2006/08/10 09:00 CRDT- 2006/06/21 09:00 PHST- 2006/06/21 09:00 [pubmed] PHST- 2006/08/10 09:00 [medline] PHST- 2006/06/21 09:00 [entrez] AID - 177/1/468 [pii] AID - 10.4049/jimmunol.177.1.468 [doi] PST - ppublish SO - J Immunol. 2006 Jul 1;177(1):468-78. doi: 10.4049/jimmunol.177.1.468.